DSECT/DSEN Seminar Series: Drug Benefits Management: A Focus on Cancer
Public drug funders in Canada face common issues of value, affordability and sustainability in their drug programs. Oncology in particular is a field where new therapies have very high drug costs yet where there may be multiple questions about a drug’s effectiveness, safety and value at the time of market launch.
This presentation by Scott Gavura will provide an overview of the current drug funding decision-making processes with a focus on the pathways established for cancer drugs. The sustainability challenge facing the cancer system will be described and recent initiatives will be summarized.
- Specialty Therapies and Biosimilars Congress
- Jan 22 2020 - Jan 24 2020
- All of the day